The New Generation Of Banging Hardtechno Forum Index The New Generation Of Banging Hardtechno
The New Generation Of Banging Hardtechno
 
 FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   GalleriesGalleries   RegisterRegister 
 ProfileProfile   Log in to check your private messagesLog in to check your private messages   Log inLog in 

PPD Acquires Two Research Organizations in China

 
Post new topic   Reply to topic    The New Generation Of Banging Hardtechno Forum Index -> Dariush Gee
View previous topic :: View next topic  
Author Message
241nneb51b3h
Newbie



Joined: 13 Dec 2010
Posts: 31
Read: 0 topics

Warns: 0/5
Location: England

PostPosted: Fri 5:52, 11 Mar 2011    Post subject: PPD Acquires Two Research Organizations in China

PPD Inc. has announced two deals in as many days.
The Wilmington-based contract research organization said Wednesday that it has agreed to acquire BioDuro LLC in a move that will expand its drug capabilities in China.
BioDuro, described as a drug discovery outsourcing company,[link widoczny dla zalogowanych], operates a laboratory in Beijing. Most of its 660 employees are based in China,[link widoczny dla zalogowanych], PPD said.
When the deal closes, expected in the fourth quarter, PPD will employ nearly 1,000 in China, making it the largest CRO to offer clinical development and discovery services in that country, the company said.
PPD and BioDuro will perform research and development services for large pharmaceutical clients from early stage through Phase IV development.
PPD cited Barclays Capital as saying biopharmaceutical companies spend $20.2 billion on drug discovery research annually. Of that, $1.6 billion is outsourced now, but that is expected to grow to $5 billion to $10 billion in the next three to five years.
The BioDuro deal will position PPD "to be the full-service CRO of choice in China," CEO David Grange said in a statement.
Additionally, PPD recently acquired Excel PharmaStudies, the market leader and one of the largest CROs in China.
On Tuesday, PPD said it will collaborate with Janssen Pharmaceutia N.V. to develop and commercialize two compounds, one to treat diarrhea-predominant irritable bowel syndrome and the other to treat complicated skin and skin structure and respiratory infections.
Under the agreement,[link widoczny dla zalogowanych], PPD could receive millions of dollars in milestone payments and royalties.
PPD said it will advance the compounds through Phase II development. When Phase II is completed,[link widoczny dla zalogowanych], Janssen will have the option to develop and commercialize the compounds.
In exchange,[link widoczny dla zalogowanych], PPD would receive up to $330 million in clinical and sales milestones and royalties on sales of the compounds if they are approved for marketing.


The post has been approved 0 times
Back to top
View user's profile
Display posts from previous:   
Post new topic   Reply to topic    The New Generation Of Banging Hardtechno Forum Index -> Dariush Gee All times are GMT + 2 Hours
Page 1 of 1

 
Jump to:  
You can post new topics in this forum
You can reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum

fora.pl - załóż własne forum dyskusyjne za darmo
Powered by phpBB © 2001, 2005 phpBB Group
Regulamin